{"version":"1.0","provider_name":"All About Cardiovascular System and Disorders","provider_url":"https:\/\/johnsonfrancis.org\/professional","author_name":"Johnson Francis","author_url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/","title":"ARCADIA Trial on Atrial Cardiopathy and Stroke - All About Cardiovascular System and Disorders","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"LPKnbfUL5b\"><a href=\"https:\/\/johnsonfrancis.org\/professional\/arcadia-trial-on-atrial-cardiopathy-and-stroke\/\">ARCADIA Trial on Atrial Cardiopathy and Stroke<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/johnsonfrancis.org\/professional\/arcadia-trial-on-atrial-cardiopathy-and-stroke\/embed\/#?secret=LPKnbfUL5b\" width=\"600\" height=\"338\" title=\"&#8220;ARCADIA Trial on Atrial Cardiopathy and Stroke&#8221; &#8212; All About Cardiovascular System and Disorders\" data-secret=\"LPKnbfUL5b\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/johnsonfrancis.org\/professional\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/ARCADIA-Trial-on-Atrial-Cardiopathy-and-Stroke.jpg","thumbnail_width":1200,"thumbnail_height":894,"description":"In an earlier post on Embolic Stroke of Undetermined Source (ESUS), I had mentioned about ARCADIA trial (AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke) which was testing whether there is role for apixaban compared to aspirin for prevention of recurrent stroke in ESUS. The trial was sponsored by the National Institutes of [&hellip;]"}